Last 47 quarters of trend data · Healthcare · Medical Supplies & Consumables
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -84.20 | 205.88 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 3.15 | 4.32 | 4.26 | 6.16 | 4.26 | 4.06 | 3.03 | 5.00 | 3.83 | 3.60 | 3.29 | 3.91 | 4.40 | 5.67 | 6.49 | 5.51 | 3.24 | 4.34 | 5.11 | 5.15 | 5.23 |
| — | +6.4% | +40.5% | +23.2% | +11.3% | +12.6% | -7.9% | +27.9% | -13.0% | -36.5% | -49.3% | -29.1% | +36.0% | +30.7% | +26.9% | +7.1% | -38.1% | -53.4% | -28.2% | -68.3% | -60.1% | |
| P/B Ratio | 8.37 | 11.52 | 11.84 | 15.74 | 10.76 | 10.01 | 7.15 | 10.51 | 7.06 | 6.49 | 5.64 | 5.52 | 4.49 | 5.60 | 6.44 | 5.17 | 3.09 | 3.48 | 3.67 | 3.66 | 3.43 |
| — | +15.1% | +65.6% | +49.7% | +52.4% | +54.2% | +26.6% | +90.4% | +57.1% | +15.9% | -12.4% | +6.7% | +45.3% | +60.7% | +75.5% | +41.2% | -10.0% | -37.0% | -10.4% | -49.7% | -57.0% | |
| P/FCF | 538.71 | — | — | 97.66 | 3413.54 | — | — | 44.94 | — | — | — | 31.18 | — | — | — | 36.40 | — | — | — | — | — |
| — | — | — | +117.3% | — | — | — | +44.1% | — | — | — | -14.3% | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | 60.60 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | 196.41 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 62.3% | 65.1% | 59.8% | 62.6% | 60.2% | 63.5% | 62.8% | 62.9% | 63.4% | 65.0% | 62.3% | 60.3% | 62.0% | 56.1% | 56.1% | 55.5% | 55.7% | 51.1% | 58.0% | 59.0% | 57.9% |
| — | +2.5% | -4.7% | -0.6% | -5.0% | -2.3% | +0.8% | +4.4% | +2.3% | +16.0% | +11.0% | +8.5% | +11.3% | +9.7% | -3.3% | -5.9% | -3.8% | -12.0% | -2.5% | +4.3% | -10.7% | |
| Operating Margin | -7.2% | 5.2% | -7.4% | -5.0% | -8.3% | -3.1% | -12.9% | -18.0% | -20.8% | -14.1% | -23.9% | -30.6% | -25.6% | -46.5% | -41.3% | -34.2% | -19.7% | -55.2% | -50.1% | -32.6% | -21.9% |
| — | +269.7% | +43.1% | +72.1% | +59.9% | +78.3% | +46.0% | +41.2% | +18.6% | +69.6% | +42.1% | +10.6% | -29.8% | +15.8% | +17.4% | -5.0% | +9.9% | -120.9% | -22.9% | -13.4% | -470.9% | |
| Net Margin | -6.4% | 2.1% | -6.9% | -4.5% | -7.5% | -2.0% | -12.1% | -17.7% | -19.3% | -11.7% | -23.6% | -103.9% | -19.5% | -36.0% | -32.6% | -26.9% | -15.8% | -44.6% | -40.6% | -16.5% | -18.1% |
| — | +203.3% | +43.3% | +74.7% | +61.3% | +82.7% | +48.7% | +83.0% | +1.1% | +67.4% | +27.6% | -286.0% | -23.7% | +19.4% | +19.7% | -63.5% | +12.8% | -119.4% | -72.9% | +20.0% | -541.8% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -15.6% | 1.4% | -4.8% | -2.9% | -4.7% | -1.3% | -7.0% | -9.0% | -8.7% | -5.2% | -9.8% | -31.2% | -4.9% | -8.6% | -7.9% | -6.2% | -3.8% | -8.7% | -7.1% | -2.9% | -3.0% |
| — | +214.7% | +32.4% | +67.9% | +45.6% | +75.9% | +28.3% | +71.1% | -76.1% | +39.4% | -24.3% | -404.4% | -30.9% | +0.5% | -10.8% | -112.5% | -27.4% | -189.2% | -106.2% | -32.9% | -569.4% | |
| ROA | -9.5% | 0.9% | -2.8% | -1.8% | -3.0% | -0.8% | -4.3% | -5.7% | -5.8% | -3.6% | -6.9% | -23.4% | -3.8% | -6.7% | -6.0% | -4.7% | -2.9% | -6.8% | -6.0% | -2.6% | -2.7% |
| — | +213.8% | +33.7% | +69.2% | +48.8% | +78.3% | +38.1% | +75.6% | -50.7% | +46.3% | -15.6% | -403.1% | -33.2% | +1.2% | +0.1% | -79.9% | -7.9% | -151.0% | -93.1% | -32.2% | -598.9% | |
| ROIC | -19.5% | 3.8% | -5.6% | -3.5% | -5.5% | -2.0% | -8.3% | -9.8% | -10.1% | -7.2% | -11.4% | -9.5% | -6.4% | -11.3% | -11.2% | -9.4% | -5.7% | -15.2% | -16.4% | -13.7% | -8.9% |
| — | +290.4% | +32.4% | +64.0% | +45.2% | +72.2% | +27.5% | -2.6% | -57.1% | +35.9% | -2.1% | -1.0% | -11.7% | +25.6% | +31.9% | +31.2% | +35.6% | -62.1% | -0.4% | -32.3% | -310.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.21 | 0.18 | 0.20 | 0.21 | 0.22 | 0.21 | 0.23 | 0.24 | 0.24 | 0.21 | 0.22 | 0.22 | 0.17 | 0.15 | 0.15 | 0.16 | 0.16 | 0.14 | 0.13 | 0.02 | 0.02 |
| — | -14.5% | -12.9% | -13.6% | -6.8% | -1.1% | +4.6% | +8.7% | +41.9% | +39.5% | +41.3% | +38.9% | +8.3% | +9.2% | +17.7% | +849.9% | +611.8% | +2995.8% | +2336.3% | +149.9% | +217.5% | |
| Debt / EBITDA | — | 3.87 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 2.44 | 2.72 | 2.33 | 2.44 | 2.48 | 2.91 | 2.44 | 2.66 | 2.99 | 3.77 | 4.01 | 4.55 | 5.14 | 5.53 | 5.57 | 4.28 | 4.98 | 5.40 | 7.20 | 7.79 | 8.26 |
| — | -6.5% | -4.5% | -8.2% | -17.2% | -22.9% | -39.3% | -41.6% | -41.7% | -31.8% | -28.0% | +6.2% | +3.0% | +2.3% | -22.6% | -45.0% | -39.6% | -51.8% | -16.5% | -23.9% | +3.8% | |
| Quick Ratio | 1.99 | 2.09 | 1.82 | 1.99 | 1.92 | 2.25 | 2.02 | 2.27 | 2.37 | 3.27 | 3.37 | 3.77 | 4.03 | 4.23 | 4.11 | 3.36 | 3.87 | 4.22 | 5.92 | 6.51 | 6.73 |
| — | -7.2% | -9.7% | -12.2% | -19.2% | -31.0% | -40.1% | -39.8% | -41.1% | -22.9% | -18.0% | +12.0% | +4.1% | +0.3% | -30.7% | -48.4% | -42.5% | -52.7% | -13.5% | -22.2% | -2.5% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -2137.06 | -556.09 | -465.83 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying KRMD stock.
KORU Medical Systems, Inc.'s current P/E is -84.2x. The average P/E over the last 1 quarters is 205.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
KORU Medical Systems, Inc.'s current operating margin is -7.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking KORU Medical Systems, Inc.'s business trajectory between earnings reports.